Astellas Pharma Inc.

Astellas Pharma Inc. - Tokyo, Japan; In spring 2005, Astellas Pharma Inc. was formed from the merger of Fujisawa Pharmaceutical and Yamanouchi Pharmaceutical

Related product monographs:

1. Insulin-like Growth Factor-1, rDNA/Tercica -- Japan mark.
2. Interferon alfacon-1, rDNA -- Intl. mark.
3. Interleukin-11, rDNA -- Japan mark.
4. LFA-3/IgG1, rDNA -- World mark.
5. Platelet Mab Fab, rDNA -- Japan mark.
6. Somatropin, rDNA/Novo Nordisk -- Japan mark.

Location - Tokyo Japan FOR

Further information:
Description, ordering information, etc.
Order/Inquiry
Products Database

Copyright ©2020. Biotechnology Information Institute